LifeStance Health Group ( LFST ) Reports Q2 Loss, Tops Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of +66.67% and +0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LifeStance ( LFST ) Q2 Revenue Jumps 11%
LifeStance Health Group ( NASDAQ:LFST ) , a large U.S. outpatient mental healthcare provider, reported its financial results for the second quarter of fiscal 2025 on August 7, 2025. The most notable news was that revenue ( GAAP ) reached $345.3 million, slightly exceeding analyst expectations and ...
LifeStance Reports Second Quarter 2025 Results
SCOTTSDALE, Ariz., Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( Nasdaq: LFST ) , one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2025.
Bet on 5 Top-Ranked Stocks With Rising P/E
CSW, ASAN, and others show rising P/E trends -- suggesting breakout potential backed by strong earnings surprises.
LifeStance Health ( LFST ) Upgraded to Strong Buy: What Does It Mean for the Stock?
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health ( LFST )
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...
Wall Street Analysts Think LifeStance Health ( LFST ) Could Surge 45.04%: Read This Before Placing a Bet
The consensus price target hints at a 45% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference - LifeStance Health Gr ( NASDAQ:LFST )
SCOTTSDALE, Ariz., May 28, 2025 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. LFST, one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in ...
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference
SCOTTSDALE, Ariz., May 28, 2025 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( NASDAQ: LFST ) , one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will ...
This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Commercial Metals ( NYSE:CMC ) , BellRing Brands ( NYSE:BRBR )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Mitchell Kapoor upgraded Kyverna Therapeutics, Inc.
LifeStance Health ( LFST ) Upgraded to Strong Buy: Here's Why
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Down -20.26% in 4 Weeks, Here's Why LifeStance Health ( LFST ) Looks Ripe for a Turnaround
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the ...
LifeStance Health Group ( LFST ) Reports Break-Even Earnings for Q1
LifeStance Health (LFST) delivered earnings and revenue surprises of 100% and 0.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Reports First Quarter 2025 Results
SCOTTSDALE, Ariz., May 07, 2025 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( Nasdaq: LFST ) , one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025.
Wall Street Analysts Believe LifeStance Health ( LFST ) Could Rally 28.68%: Here's is How to Trade
The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LifeStance Health Group ( LFST ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Addus HomeCare ( ADUS ) Surges 4.9%: Is This an Indication of Further Gains?
Addus HomeCare (ADUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LifeStance Health ( LFST ) Surges 5.8%: Is This an Indication of Further Gains?
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Wall Street Analysts See a 26.63% Upside in LifeStance Health ( LFST ) : Can the Stock Really Move This High?
The mean of analysts' price targets for LifeStance Health (LFST) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
This Talkspace Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday - Kairos Pharma ( AMEX:KAPA ) , Equity Bancshares ( NYSE:EQBK )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Kairos Pharma, Ltd.
LifeStance Health ( LFST ) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the ...
LifeStance Health Group ( LFST ) Reports Q4 Loss, Tops Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of 50% and 4.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Reports Fourth Quarter and Full Year 2024 Results
SCOTTSDALE, Ariz., Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( Nasdaq: LFST ) , one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024.
Analysts Estimate RadNet ( RDNT ) to Report a Decline in Earnings: What to Look Out for
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LifeStance Health Group ( LFST ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare Q4 Earnings Miss Estimates on Growing Medical Costs
MOH expects total membership to be at 5.9 million by 2025-end.
Best Momentum Stocks to Buy for January 29th
EAT, LFST and MC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 29, 2024.
New Strong Buy Stocks for January 29th
MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024.
Here's Why You Should Add Ensign Stock to Your Portfolio Now
ENSG's valuation looks relatively cheap compared with the industry average.
LifeStance Health ( LFST ) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Mixed Bag for UnitedHealth: Q4 Earnings Beat, Revenues Fall Short
UNH projects revenues between $450 billion and $455 billion for 2025.
LifeStance Health Group ( LFST ) Reports Q3 Loss, Tops Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of 71.43% and 3.72%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Reports Third Quarter 2024 Results
SCOTTSDALE, Ariz., Nov. 07, 2024 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( Nasdaq: LFST ) , one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024.
Amedisys ( AMED ) Q3 Earnings and Revenues Lag Estimates
Amedisys (AMED) delivered earnings and revenue surprises of -12.28% and 0.08%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
ATI Physical Therapy, Inc. ( ATIP ) Reports Q3 Loss, Tops Revenue Estimates
ATI Physical Therapy (ATIP) delivered earnings and revenue surprises of -56.73% and 3.05%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Analysts Think LifeStance Health Could Surge 26.68%: Read This Before Placing a Bet - LifeStance Health Gr ( NASDAQ:LFST )
LifeStance Health Group LFST closed the last trading session at $6.26, gaining 11.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.93 indicates a 26.7% upside ...
Wall Street Analysts Think LifeStance Health ( LFST ) Could Surge 26.68%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference - LifeStance Health Gr ( NASDAQ:LFST )
SCOTTSDALE, Ariz., Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. LFST, one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 22nd Annual Morgan Stanley Global Healthcare Conference, which will be ...
LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference
SCOTTSDALE, Ariz., Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( NASDAQ: LFST ) , one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 22nd Annual Morgan Stanley Global Healthcare Conference, ...
Bragar Eagel & Squire, P.C. Is Investigating LifeStance and Customers Bancorp and Encourages Investors to Contact the Firm - Customers Bancorp ( NYSE:CUBI ) , LifeStance Health Gr ( NASDAQ:LFST )
NEW YORK, Aug. 19, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims LifeStance Health Group, Inc. LFST and Customers Bancorp, Inc.
Wall Street Analysts Believe LifeStance Health ( LFST ) Could Rally 39.38%: Here's is How to Trade
The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LifeStance Reports Second Quarter 2024 Results
SCOTTSDALE, Ariz., Aug. 08, 2024 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. ( Nasdaq: LFST ) , one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2024.
Encompass Health ( EHC ) Q2 Earnings Beat Estimates
Encompass Health (EHC) delivered earnings and revenue surprises of 9.90% and 0.25%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Health Group ( LFST ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
LifeStance Health (LFST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does LifeStance Health ( LFST ) Have the Potential to Rally 54.84% as Wall Street Analysts Expect?
The mean of analysts' price targets for LifeStance Health (LFST) points to a 54.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
All You Need to Know About LifeStance Health ( LFST ) Rating Upgrade to Strong Buy
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024 - LifeStance Health Gr ( NASDAQ:LFST )
SCOTTSDALE, Ariz., July 18, 2024 ( GLOBE NEWSWIRE ) -- LifeStance Health Group, Inc. LFST, one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024.
Experts Reveal How To Support Mental Health On A Weight Loss Journey
It's estimated that one in eight U.S. adults has used a GLP-1 agonist medication, according to a survey from health policy research organization KFF that was released in May of 2024.
Wall Street Analysts See a 57.38% Upside in LifeStance Health: Can the Stock Really Move This High? - LifeStance Health Gr ( NASDAQ:LFST )
Shares of LifeStance Health Group LFST have gained 1.3% over the past four weeks to close the last trading session at $5.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication.
Peering Into LifeStance Health Gr's Recent Short Interest - LifeStance Health Gr ( NASDAQ:LFST )
LifeStance Health Gr's LFST short percent of float has fallen 5.99% since its last report. The company recently reported that it has 16.01 million shares sold short, which is 20.1% of all regular shares that are available for trading.
